Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
K. G. Lokugamage, A. Hage, M. Devries, A. M. Vallero-Jimenez, C. Schindewolf, M. Dittmann, R. Rajsbaum, V. D. Menachery
This study compares the sensitivity of SARS-CoV-2 and SARS-CoV to type I interferon, finding SARS-CoV-2 is more susceptible to IFN-I treatment.
Journal of Virology · Nov 9, 2020Peer-reviewedMicrobiology